Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT07020065 |
Title | Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Swiss Group for Clinical Cancer Research |
Indications | |
Therapies | |
Age Groups: | senior |
Covered Countries | CHE |